To our knowledge, this is the first report to demonstrate the neuroprotective effect of hyperoside against 6-OHDA-induced oxidative damage in human dopaminergic SH-SY5Y cells via the Nrf2-mediated HO-1 signaling pathway in a cellular PD model. This evidence concerns the gene NFE2L2 and Parkinson disease.